Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agex Therapeutics Inc (NY: AGE )

0.3690 +0.0020 (+0.54%)
Official Closing Price Updated: 6:30 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 115,169
Open 0.3758
Bid (Size) 0.3500 (1)
Ask (Size) 0.3726 (11)
Prev. Close 0.3670
Today's Range 0.3400 - 0.3758
52wk Range 0.3321 - 1.000
Shares Outstanding 37,951,261
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's Going On With Penny Stock AgeX Therapeutics?
Serina Therapeutics Inc, a privately held, clinical-stage biotechnology company, entered into a License Agreement under which Pfizer Inc (NYSE: PFE) will license, on a non-exclusive basis, Serina's  
Via Benzinga
AgeX Therapeutics Reports Third Quarter 2023 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire

Performance

YTD
-33.99%
-33.99%
1 Month
-38.50%
-38.50%
3 Month
-51.45%
-51.45%
6 Month
-29.04%
-29.04%
1 Year
-34.11%
-34.11%

More News

Read More
AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE
From Kahn Swick & Foti, LLC
Via Business Wire
AGE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AgeX Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Reports Second Quarter 2023 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock
From AgeX Therapeutics, Inc.
Via Business Wire
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
AgeX Therapeutics Announces Appeal of NYSE American Determination
From AgeX Therapeutics, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
AgeX Therapeutics Reports First Quarter 2023 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Receives Stock Exchange Deficiency Letter
From AgeX Therapeutics , Inc.
Via Business Wire
AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Reports Third Quarter 2022 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Reports Second Quarter 2022 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Via Benzinga
Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Reports First Quarter 2022 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
60 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.